Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wearing-Off Period of Pharmacological Dilation in Anisocoria
NCT05238233Phase 4Completed
- Sponsor
- Prisma Health
- Start
- Apr 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tropicamide, pilocarpine in anisocoria, sponsored by Prisma Health. Started Apr 2022; status: completed.
02
Drugs
tropicamidepilocarpine
03
Conditions
anisocoria
Beyond the preview
Go deeper on NCT05238233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05238233.